Globe Buddy enters Baltics through Euromedika partnership
Bottom line
Danish alternative-protein pet food brand Globe Buddy is entering the Baltic market through a new distribution partnership with Lithuania-based Euromedika, with launches planned across Lithuania, Latvia, and Estonia. Trade coverage says the initial rollout centers on Globe Buddy’s dog treat portfolio, including its newer Hearts line, plus selected products from its Luxx range. Globe Buddy positions itself around alternative proteins and plant-based ingredients, and says its products are made in the EU. (petfoodprocessing.net)
Why it matters: For veterinary professionals, the move adds another alternative-protein option to the Baltic pet food landscape at a time when sustainability, ingredient differentiation, and functional positioning are becoming more visible in companion animal nutrition. While this is a distribution story, not a clinical one, it points to broader market expansion for insect-protein and plant-based products in Europe, where harmonized pet food labeling and market rules can make cross-border rollout easier once a partner is in place. (fediaf.org)
What to watch: Watch whether Globe Buddy expands beyond treats into complete diets in the Baltics, and whether veterinary channels become part of Euromedika’s go-to-market strategy. (petfoodindustry.com)
Danish pet food company Globe Buddy is expanding into the Baltic states through a new partnership with Lithuania-based Euromedika, marking the brand’s entry into Lithuania, Latvia, and Estonia. The announcement, first reported by Pet Food Processing and PetfoodIndustry in late August 2026, gives Globe Buddy a regional distribution foothold for its alternative-protein pet food portfolio. (petfoodprocessing.net)
The move fits Globe Buddy’s broader international growth strategy. On its LinkedIn page, the company said it is actively exploring additional distribution partnerships across several European markets, including Germany, Italy, France, Spain, the UK, and Sweden. Globe Buddy, founded in 2019 and based in Denmark, markets dog food and treats built around alternative proteins and plant-based ingredients, including insect-based recipes and Vegan Society-certified snacks. (dk.linkedin.com)
In the Baltics, the initial launch appears focused on treats rather than a full-line rollout. PetfoodIndustry reported that the launch includes Globe Buddy’s Hearts everyday dog treats, with two insect-protein recipes and one vegan variety, along with products from the Luxx line such as Luxx Easy and Luxx Energy. The company’s website also highlights broader dry food offerings, suggesting the Baltic launch could be a first step rather than the endpoint of the assortment. (petfoodindustry.com)
Globe Buddy’s own announcement emphasized partner selection and local market knowledge. In its LinkedIn post, the company said it wanted a distributor that understands local markets and can help introduce the brand’s “quality, functional nutrition and carefully selected ingredients” to retailers, veterinary professionals, and dog caregivers in the region. That language is notable because it suggests Globe Buddy sees veterinary stakeholders as part of the conversation even if the first commercial push is retail-led. (dk.linkedin.com)
Independent expert reaction specifically on this deal was limited in public coverage at the time of writing. Still, industry context helps explain the significance. FEDIAF says 140 million EU households own a pet, with annual European pet food sales of €29.4 billion, underscoring why smaller regional expansions matter for emerging brands. Separate industry reporting has described the Baltics as a growth market where pet parents are increasingly willing to spend on premium products, even amid broader economic pressure. (fediaf.org)
Why it matters: For veterinary professionals, this is less about an immediate medical practice change and more about the steady normalization of alternative proteins in mainstream pet nutrition. As more brands enter more markets, clinicians can expect more questions from pet parents about insect protein, plant-based treats, digestibility, sustainability claims, and how these products fit into balanced feeding plans. The partnership also highlights how distribution, not just formulation, shapes what diets and treat formats are actually available in local markets. In Europe, harmonized guidance on labeling and feed hygiene can support cross-border launches, but product claims and nutritional use still need careful interpretation in practice. (fediaf.org)
That may be especially relevant in the Baltics, where competitive activity has been building. Prior reporting has pointed to growth in regional pet food demand and to continued investment by established players across Lithuania, Latvia, and Estonia. For newer brands like Globe Buddy, securing a local distribution partner can be the difference between niche visibility and real shelf presence. (globalpetindustry.com)
What to watch: The next signal will be assortment depth and channel strategy: whether Globe Buddy broadens from treats into complete diets, whether Euromedika builds out veterinary-facing education or retail support, and whether the company uses the Baltic launch as a template for further European expansion over the next 6 to 12 months. That forward view is an inference based on Globe Buddy’s stated interest in additional markets and the staged nature of the current rollout. (dk.linkedin.com)